Target Entity: KMHP Ventures Limited

Type of Deal: Investment via rights issue in wholly-owned subsidiary

Stake/Capacity: 21,00,000 equity shares acquired. Post-acquisition, KMHP Ventures Limited continues to remain a wholly-owned subsidiary of Zota Health Care Limited.

Deal Value: ₹2,10,00,000.00 (₹2.10 crore)

Funding Source: Cash consideration

Financial Impact:

  • The investment is intended to fund the rollout of retail stores under the brand "Ugo Generic"
  • Mitigate working capital requirements of KMHP Ventures Limited
  • KMHP Ventures Limited reported turnover of Rs. NIL for Financial Year 2025-26
  • Total paid-up share capital of KMHP Ventures Limited is Rs. 210.00 lakhs post-acquisition

Timeline: Acquisition completed on October 01, 2026

Strategic Rationale:

  • Strategic investment to support KMHP Ventures' expansion into pharmaceutical retail
  • Rollout of retail stores under the brand name "Ugo Generic" operating in both Business to Business (B2B) and Business to Consumer (B2C) models
  • Offering high quality generic medicines on a PAN India basis through owned stores
  • Targeting onboarding of approximately 12.5 lakh retail pharmacies under Ugo Generic
  • Expansion of store network
  • Working capital mitigation for the subsidiary

Approval Status: Transaction completed on October 01, 2026. No governmental or regulatory approvals required as indicated by "N.A." in the document.

Additional Company Background:

  • KMHP Ventures Limited was incorporated on January 13, 2026
  • Domiciled in India
  • Engaged in the pharmaceutical segment
  • Financial history:
  • FY 2025-26: Rs. NIL turnover
  • FY 2024-25: N.A.
  • FY 2023-24: N.A.

Transaction Details:

  • Not a related party transaction
  • Promoter/promoter group/group companies do not have any interest in KMHP Ventures Limited
  • Transaction executed at arm's length basis
  • Acquisition price: ₹10.00 per equity share